Literature DB >> 1667926

A proposal for the molecular basis of mu and delta opiate receptor differentiation based on modeling of two types of cyclic enkephalins and a narcotic alkaloid.

A Michel1, G Villeneuve, J DiMaio.   

Abstract

The molecular basis underlying the divergent receptor selectivity of two cyclic opioid peptides Tyr-c[N delta-D-Orn2-Gly-Phe-Leu-] (c-ORN) and [D-Pen2,L-Cys5]-enkephalinamide (c-PEN) was investigated using a molecular modeling approach. Ring closure and conformational searching procedures were used to determine low-energy cyclic backbone conformers. Following reinsertion of amino acid side chains, the narcotic alkaloid 7 alpha-[(1R)-1-methyl-1-hydroxy-3-phenylpropyl]-6-14-endoethenotetrahy dro oripavine (PEO) was used as a flexible template for bimolecular superpositions with each of the determined peptide ring conformers using the coplanarity and cocentricity of the phenolic rings as the minimum constraint. A vector space of PEO, accounting for all possible orientations for the C21-aromatic ring of PEO served as a geometrical locus for the aromatic ring of the Phe4 residue in the opioid peptides. Although a vast number of polypeptide conformations satisfied the criteria of the opiate pharmacophore, they could be grouped into three classes differing in magnitude and sign of the torsional angle values of the tyrosyl side chain. Only class III conformers for both c-ORN and c-PEN, having tyramine dihedral angles chi 1 = 150 degrees +/- 30 degrees and chi 2 = -155 degrees +/- 20 degrees, had significant structural and conformational properties that were mutually compatible while respecting the PEO vector space. Comparison of these properties in the context of the divergent receptor selectivity of the studied opioid peptides suggests that the increased distortion of the peptide backbone in the closure region of c-PEN together with the pendant beta,beta-dimethyl group, combine to generate a steric volume which is absent in c-ORN and that may be incompatible with a restrictive topography of the mu receptor. The nature and stereochemistry of substituents adjacent to the closure region of the peptides could also modulate receptor selection by interacting with a charged (delta) or neutral (mu) subsite.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667926     DOI: 10.1007/bf00135314

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  44 in total

1.  Biosynthetic origin and receptor conformation of methionine enkephalin.

Authors:  A F Bradbury; D G Smyth; C R Snell
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

2.  Application of the message-address concept in the design of highly potent and selective non-peptide delta opioid receptor antagonists.

Authors:  P S Portoghese; M Sultana; H Nagase; A E Takemori
Journal:  J Med Chem       Date:  1988-02       Impact factor: 7.446

3.  Theoretical conformational analysis of a mu-selective cyclic opioid peptide analog.

Authors:  B C Wilkes; P W Schiller
Journal:  Biopolymers       Date:  1987-08       Impact factor: 2.505

4.  10-Hydroxy-4-methyl-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonine derivatives (homobenzomorphans) as analgesics.

Authors:  S Shiotani; T Kometani
Journal:  J Med Chem       Date:  1976-06       Impact factor: 7.446

5.  Cyclic enkephalin analogs containing a cystine bridge.

Authors:  P W Schiller; B Eggimann; J DiMaio; C Lemieux; T M Nguyen
Journal:  Biochem Biophys Res Commun       Date:  1981-07-30       Impact factor: 3.575

6.  A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.

Authors:  P S Portoghese; D L Larson; L M Sayre; D S Fries; A E Takemori
Journal:  J Med Chem       Date:  1980-03       Impact factor: 7.446

7.  Side-chain torsional potentials: effect of dipeptide, protein, and solvent environment.

Authors:  B R Gelin; M Karplus
Journal:  Biochemistry       Date:  1979-04-03       Impact factor: 3.162

8.  Topological similarities between a cyclic enkephalin analogue and a potent opiate alkaloid: a computer-modeling approach.

Authors:  J DiMaio; C I Bayly; G Villeneuve; A Michel
Journal:  J Med Chem       Date:  1986-09       Impact factor: 7.446

9.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate.

Authors:  E J Simon; J M Hiller; I Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

10.  A cyclic enkephalin analog with high in vitro opiate activity.

Authors:  J DiMaio; P W Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.